|
US1995A
(en)
|
|
1841-03-03 |
|
Latch of door and other locks |
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
WO1988006451A1
(en)
|
1987-02-24 |
1988-09-07 |
Xoma Corporation |
Immunosuppression in immunotoxin based human therapy
|
|
US5912017A
(en)
|
1987-05-01 |
1999-06-15 |
Massachusetts Institute Of Technology |
Multiwall polymeric microspheres
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
JP2670680B2
(ja)
|
1988-02-24 |
1997-10-29 |
株式会社ビーエムジー |
生理活性物質含有ポリ乳酸系微小球およびその製造法
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5268455A
(en)
|
1989-05-25 |
1993-12-07 |
Genentech, Inc. |
Process for making biologically active polypeptides based on transforming growth factor-βsequences
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5843452A
(en)
|
1992-11-09 |
1998-12-01 |
Pharmagenesis, Inc. |
Immunotherapy composition and method
|
|
US5679347A
(en)
|
1992-12-10 |
1997-10-21 |
Brigham And Women's Hospital |
Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
|
|
DE69418699T2
(de)
|
1993-01-11 |
1999-09-30 |
Dana-Farber Cancer Institute, Boston |
Induktion der antworten zytotoxischer t-lymphozyten
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
WO1995003035A1
(en)
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5468729A
(en)
|
1993-10-26 |
1995-11-21 |
Alpha 1 Biomedicals |
Method for treatment of autoimmune hepatitis
|
|
WO1995031480A1
(en)
|
1994-05-18 |
1995-11-23 |
S.P.I. Synthetic Peptides Incorporated |
Heterodimer polypeptide immunogen carrier composition and method
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5814617A
(en)
*
|
1994-10-07 |
1998-09-29 |
The United States Of America As Represented By The Secretary Of The Navy |
Protective 17 KDA malaria hepatic and erythrocytic stage immunogen and gene
|
|
JPH10507758A
(ja)
|
1994-10-19 |
1998-07-28 |
ジェネティック セラピー，インコーポレイテッド |
アデノウイルスおよび免疫抑制剤同時反復投与を伴う遺伝子治療
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
ATE252894T1
(de)
|
1995-01-05 |
2003-11-15 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
|
US6251957B1
(en)
|
1995-02-24 |
2001-06-26 |
Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
JP3462313B2
(ja)
|
1995-08-24 |
2003-11-05 |
キッコーマン株式会社 |
変異型ウリカーゼ、変異型ウリカーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ウリカーゼの製造法
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
WO1998002441A2
(en)
|
1996-07-12 |
1998-01-22 |
Ariad Pharmaceuticals, Inc. |
Non immunosuppressive antifungal rapalogs
|
|
EP0889954A1
(en)
|
1996-09-03 |
1999-01-13 |
Health Research, Inc. |
Treatment of antigen presenting cells to modulate antigen presenting cell function
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
AU741130B2
(en)
|
1997-09-16 |
2001-11-22 |
Oregon Health Sciences University |
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
|
|
PL187544B1
(pl)
|
1997-10-30 |
2004-07-30 |
C B F Leti Sa |
Wywołujące tolerancję fragmenty naturalnych alergenów
|
|
US6018817A
(en)
|
1997-12-03 |
2000-01-25 |
International Business Machines Corporation |
Error correcting code retrofit method and apparatus for multiple memory configurations
|
|
US6197229B1
(en)
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
|
WO1999032647A1
(en)
|
1997-12-23 |
1999-07-01 |
Introgene B.V. |
Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into the chromosomal dna of target cells
|
|
JP2002500198A
(ja)
|
1998-01-09 |
2002-01-08 |
サーカシア リミテッド |
脱感作のための方法及び組成物
|
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
SE9801288D0
(sv)
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
PL202799B1
(pl)
|
1998-08-06 |
2009-07-31 |
Mountain View Pharmaceuticals |
Sposób izolowania urykazy w postaci tetramerycznej oraz wyizolowana tetrameryczna urykaza
|
|
KR100731820B1
(ko)
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
US6306640B1
(en)
|
1998-10-05 |
2001-10-23 |
Genzyme Corporation |
Melanoma antigenic peptides
|
|
ATE348163T1
(de)
|
1998-10-23 |
2007-01-15 |
Amgen Inc |
Thrombopoietin substitute
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
|
ES2639020T3
(es)
|
1998-11-27 |
2017-10-25 |
Ucb Pharma S.A. |
Composiciones y métodos para incrementar la mineralización de la substancia ósea
|
|
US6153217A
(en)
*
|
1999-01-22 |
2000-11-28 |
Biodelivery Sciences, Inc. |
Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
|
|
US6800296B1
(en)
|
1999-05-19 |
2004-10-05 |
Massachusetts Institute Of Technology |
Modification of surfaces using biological recognition events
|
|
WO2000074688A1
(en)
|
1999-06-08 |
2000-12-14 |
The Children's Hospital Of Philadelphia |
Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
|
|
DE19951970A1
(de)
|
1999-10-28 |
2001-05-03 |
Bionetworks Gmbh |
Arzneimittel für die Toleranzinduktion
|
|
MXPA02008361A
(es)
|
2000-02-28 |
2004-05-17 |
Genesegues Inc |
Sistema y metodo de encapsulacion de nanocapsulas.
|
|
US20010055593A1
(en)
|
2000-03-14 |
2001-12-27 |
Joseph Sypek |
Use of rapamycin and agents that inhibit B7 activity in immunomodulation
|
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
|
WO2001091802A1
(en)
|
2000-05-30 |
2001-12-06 |
Baylor College Of Medicine |
Chimeric viral vectors for gene therapy
|
|
US7465583B2
(en)
|
2000-06-01 |
2008-12-16 |
The University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20020014242A1
(en)
|
2000-07-31 |
2002-02-07 |
Abraham Scaria |
Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
|
|
MY138883A
(en)
*
|
2000-08-29 |
2009-08-28 |
Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia |
Use of asiatic acid for treatment of cencer
|
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
AU2002338571A1
(en)
*
|
2001-04-11 |
2002-11-11 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for suppressing immune responses
|
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
CN1294268C
(zh)
|
2001-09-03 |
2007-01-10 |
上海三维生物技术有限公司 |
可在肿瘤细胞内特异性复制并扩散的重组腺病毒载体
|
|
HRP20070058B1
(hr)
|
2001-10-19 |
2014-05-23 |
Isotechnika Inc. |
Sinteza ciklosporinskih analoga
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
GB0207440D0
(en)
|
2002-03-28 |
2002-05-08 |
Ppl Therapeutics Scotland Ltd |
Tolerogenic antigen-presenting cells
|
|
US20040038303A1
(en)
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US7485314B2
(en)
|
2002-05-06 |
2009-02-03 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Induction of antigen specific immunologic tolerance
|
|
EP1549277A4
(en)
|
2002-05-22 |
2007-09-05 |
Cleveland Clinic Foundation |
INDUCING AND MAINTAINING COMPLEX TISSUE ALLOGRAFT TOLERANCE
|
|
AU2003237416A1
(en)
|
2002-06-04 |
2003-12-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Novel tolerogenic dendritic cells and therapeutic uses therefor
|
|
SG167667A1
(en)
|
2002-07-03 |
2011-01-28 |
Coley Pharm Group Inc |
Nucleic acid compositions for stimulating immune responses
|
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
|
DK1565183T3
(da)
|
2002-11-29 |
2008-12-01 |
Maria Grazia Roncarolo |
Rapamycin og IL-10 til behandling af autoimmune sygdomme
|
|
US8575110B2
(en)
|
2003-02-17 |
2013-11-05 |
Alpha-O Peptides G |
Peptidic nanoparticles as drug delivery and antigen display systems
|
|
US7510872B2
(en)
|
2003-02-26 |
2009-03-31 |
Nationwide Children's Hospital |
Recombinant adeno-associated virus production
|
|
MXPA05009556A
(es)
|
2003-03-14 |
2005-11-16 |
Wyeth Corp |
Anticuerpos contra receptor de il-21 humano y sus usos.
|
|
CN101675993A
(zh)
|
2003-03-26 |
2010-03-24 |
赛托斯生物技术公司 |
Melan-a肽类似物-病毒样颗粒偶联物
|
|
US7186699B2
(en)
|
2003-06-03 |
2007-03-06 |
Cell Genesys, Inc. |
Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
|
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
CN1835974A
(zh)
|
2003-06-16 |
2006-09-20 |
细胞技术研究与发展公司 |
对硬化素特异的抗体和用于增加骨矿化的方法
|
|
US20060251711A1
(en)
|
2003-08-28 |
2006-11-09 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal
|
|
US20080160089A1
(en)
|
2003-10-14 |
2008-07-03 |
Medivas, Llc |
Vaccine delivery compositions and methods of use
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
JP2008504216A
(ja)
|
2003-12-02 |
2008-02-14 |
サイトイミューン サイエンシズ インコーポレイテッド |
モノクローナル抗体の生成のための方法および組成物
|
|
WO2005101466A2
(en)
|
2003-12-19 |
2005-10-27 |
The University Of North Carolina At Chapel Hill |
Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
|
|
JP5080241B2
(ja)
|
2004-04-08 |
2012-11-21 |
メルク セローノ ソシエテ アノニム |
Ｊｎｋ阻害剤およびスクロスポリンを含んでなる組成物
|
|
CA2566506A1
(en)
|
2004-06-01 |
2005-12-15 |
Innogenetics N.V. |
Peptides for inducing a ctl and/or htl response to hepatitis c virus
|
|
WO2006080951A2
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
WO2006014579A2
(en)
|
2004-07-08 |
2006-02-09 |
The Regents Of California |
Enhancing class i antigen presentation with synthetic sequences
|
|
FR2874384B1
(fr)
|
2004-08-17 |
2010-07-30 |
Genethon |
Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables
|
|
EP1812061A2
(en)
|
2004-10-05 |
2007-08-01 |
Tanox Inc. |
Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy
|
|
WO2007001448A2
(en)
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
JP2008524239A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミティド |
ナノ粒子のタクロリムス製剤
|
|
CA2858733C
(en)
|
2004-12-31 |
2017-12-19 |
Iceutica Pty Ltd |
Nanoparticle compositions and methods for synthesis thereof
|
|
GB0504206D0
(en)
|
2005-03-01 |
2005-04-06 |
Glaxo Group Ltd |
Combination therapy
|
|
BRPI0608573A2
(pt)
|
2005-03-08 |
2017-07-25 |
Lifecycle Pharma As |
Composição farmacêutica, e, método para a preparação de uma composição farmacêutica.
|
|
US20060210638A1
(en)
*
|
2005-03-17 |
2006-09-21 |
Elan Pharma International Limited |
Injectable compositions of nanoparticulate immunosuppressive compounds
|
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
|
WO2006110862A2
(en)
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
|
JP2008540558A
(ja)
|
2005-05-10 |
2008-11-20 |
エモリー・ユニバーシティ |
ミセルおよび粒子を用いた、活性物質の送達のための新規の戦略
|
|
CA2611985C
(en)
|
2005-06-17 |
2016-08-16 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials
|
|
TW200711649A
(en)
*
|
2005-06-17 |
2007-04-01 |
Combinatorx Inc |
Combination therapy for the treatment of immunoinflammatory disorders
|
|
WO2007024026A1
(ja)
|
2005-08-25 |
2007-03-01 |
Taiho Pharmaceutical Co., Ltd. |
Ｔ細胞認識エピトープペプチドを固定化又は内包化した生分解性ナノ粒子
|
|
CN1979166A
(zh)
*
|
2005-11-30 |
2007-06-13 |
北京有色金属研究总院 |
一种制备免疫检测用纳米胶体金的工艺方法及其反应装置
|
|
WO2007065167A1
(en)
|
2005-12-02 |
2007-06-07 |
The Johns Hopkins University |
Use of high-dose oxazaphosphorine drugs for treating immune disorders
|
|
US20070128289A1
(en)
*
|
2005-12-07 |
2007-06-07 |
Zhao Jonathon Z |
Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases
|
|
WO2007067683A2
(en)
|
2005-12-08 |
2007-06-14 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for expanding t regulatory cells
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
US20100028450A1
(en)
|
2006-01-25 |
2010-02-04 |
The Board Of Trustees Of The University Of Illinoi S |
Tolerogenic biodegradable artificial antigen presenting system
|
|
DK1984007T3
(en)
|
2006-02-13 |
2015-12-07 |
Oncolytics Biotech Inc |
Application of Low-dose local immunosuppression for amplification of viral oncolytic therapy
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US8568487B2
(en)
|
2006-02-27 |
2013-10-29 |
Biomet Manufacturing, Llc |
Patient-specific hip joint devices
|
|
TW200806789A
(en)
|
2006-03-27 |
2008-02-01 |
Globeimmune Inc |
RAS mutation and compositions and methods related thereto
|
|
EP2012828A2
(en)
|
2006-04-28 |
2009-01-14 |
Resolvyx Pharmaceuticals, Inc. |
Compositions and methods for the treatment of cardiovascular disease
|
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
WO2007137117A2
(en)
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
EP1880729A1
(en)
|
2006-07-20 |
2008-01-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of soluble CD160 to suppress immunity
|
|
CN104177464B
(zh)
*
|
2006-08-18 |
2017-04-12 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
US20120269774A1
(en)
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
|
US8313777B2
(en)
|
2006-10-05 |
2012-11-20 |
The Johns Hopkins University |
Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
|
|
CN101646418B
(zh)
|
2006-10-12 |
2013-07-17 |
昆士兰大学 |
调节免疫应答的组合物和方法
|
|
CA2702340C
(en)
|
2006-10-12 |
2014-12-16 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
US20100112077A1
(en)
*
|
2006-11-06 |
2010-05-06 |
Abraxis Bioscience, Llc |
Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
|
|
WO2008064357A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Florida Research Foundation, Inc. |
Nanoparticles for protection of cells from oxidative stress
|
|
WO2008069942A2
(en)
|
2006-12-05 |
2008-06-12 |
Biogen Idec Ma Inc. |
Novel methods of enhancing delivery of a gene therapy vector using steroids
|
|
WO2008083331A2
(en)
|
2006-12-29 |
2008-07-10 |
The Regents Of The University Of Colorado |
Diagnostic and therapeutic target for autoimmune diseases and uses thereof
|
|
EP2112930B1
(en)
|
2007-02-21 |
2017-01-11 |
Vaccinex, Inc. |
Modulation of nkt cell activity with antigen-loaded cdid molecules
|
|
KR20080078204A
(ko)
|
2007-02-22 |
2008-08-27 |
크레아젠 주식회사 |
면역억제능이 증가된 간엽줄기세포-매개 자가유래수지상세포
|
|
JP5650406B2
(ja)
|
2007-03-07 |
2015-01-07 |
ユーティーアイ リミテッド パートナーシップ |
自己免疫状態の予防および治療のための組成物および方法
|
|
EP3417859A1
(en)
|
2007-03-07 |
2018-12-26 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
CN101730526A
(zh)
*
|
2007-03-07 |
2010-06-09 |
阿布拉科斯生物科学有限公司 |
作为抗癌剂的包含雷帕霉素和白蛋白的纳米颗粒
|
|
EP2061440A2
(en)
|
2007-04-04 |
2009-05-27 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
|
US20090074828A1
(en)
|
2007-04-04 |
2009-03-19 |
Massachusetts Institute Of Technology |
Poly(amino acid) targeting moieties
|
|
US20090226525A1
(en)
|
2007-04-09 |
2009-09-10 |
Chimeros Inc. |
Self-assembling nanoparticle drug delivery system
|
|
JP2010523656A
(ja)
|
2007-04-12 |
2010-07-15 |
エモリー・ユニバーシティ |
ミセルおよび粒子を用いた、活性物質の送達のための新規の戦略
|
|
WO2008150868A1
(en)
|
2007-05-29 |
2008-12-11 |
The Board Of Trustees Of The University Of Illinois |
Methods for inducing therapeutic t cells for immune diseases
|
|
US20080311140A1
(en)
|
2007-05-29 |
2008-12-18 |
Baylor College Of Medicine |
Antigen specific immunosuppression by dendritic cell therapy
|
|
EP2468763B1
(en)
|
2007-05-31 |
2014-06-18 |
Academisch Ziekenhuis Leiden h.o.d.n. LUMC |
HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines
|
|
AU2008258646A1
(en)
|
2007-06-05 |
2008-12-11 |
Fondazione Centro San Raffaele Del Monte Tabor |
Induction of tolerogenic phenotype in mature dendritic cells
|
|
US20090004259A1
(en)
|
2007-06-14 |
2009-01-01 |
Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) |
Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cells
|
|
WO2009007750A1
(en)
|
2007-07-09 |
2009-01-15 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
|
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
|
BRPI0815395A2
(pt)
|
2007-08-15 |
2015-02-10 |
Circassia Ltd |
Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
|
|
JP2011520769A
(ja)
*
|
2007-09-21 |
2011-07-21 |
サイトイミューン サイエンシズ インコーポレイテッド |
ナノ治療コロイド金属組成物および方法
|
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
WO2009062502A1
(en)
|
2007-11-13 |
2009-05-22 |
Dandrit Biotech A/S |
Method for generating tolerogenic dendritic cells employing decreased temperature
|
|
US20090142318A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Therakos, Inc. |
METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
|
|
JP2011512326A
(ja)
|
2007-12-31 |
2011-04-21 |
ナノコア セラピューティクス，インコーポレイテッド |
心不全の治療用のｒｎａ干渉
|
|
JP5474831B2
(ja)
|
2008-02-08 |
2014-04-16 |
テルモ株式会社 |
生理活性物質管腔内制御送達用薬剤送達装置およびその作成方法
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
CA2722184A1
(en)
|
2008-04-25 |
2009-10-29 |
Duke University |
Regulatory b cells and their uses
|
|
AU2009246169B2
(en)
|
2008-05-15 |
2015-01-22 |
Dynavax Technologies Corporation |
Long term disease modification using immunostimulatory oligonucleotides
|
|
JP5549014B2
(ja)
|
2008-05-27 |
2014-07-16 |
国立大学法人名古屋大学 |
免疫調節剤及びその利用
|
|
US20090297621A1
(en)
|
2008-06-03 |
2009-12-03 |
Abbott Cardiovascular Systems Inc. |
Microparticles For The Treatment Of Disease
|
|
AU2009268923B2
(en)
|
2008-06-16 |
2015-09-17 |
Pfizer Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
US20110070154A1
(en)
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
|
US8821887B2
(en)
|
2008-08-15 |
2014-09-02 |
Circassia Limited |
T-cell antigen peptide from allergen for stimulation of IL-10 production
|
|
US8323696B2
(en)
*
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
EP2341953B1
(en)
|
2008-09-04 |
2018-11-21 |
The General Hospital Corporation |
Hydrogels for vocal cord and soft tissue augmentation and repair
|
|
CN101676291B
(zh)
|
2008-09-18 |
2012-05-09 |
上海海和药物研究开发有限公司 |
一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途
|
|
US8889124B2
(en)
|
2008-09-25 |
2014-11-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Tolerogenic populations of dendritic cells
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
JP5552630B2
(ja)
|
2008-10-24 |
2014-07-16 |
学校法人 聖マリアンナ医科大学 |
Ｈｔｌｖ−ｉ関連脊髄症を治療または予防するための医薬、およびｈｔｌｖ−ｉ関連脊髄症の患者に対する抗体療法の効果を試験する方法
|
|
WO2010047839A1
(en)
|
2008-10-25 |
2010-04-29 |
Aura Biosciences |
Modified plant virus particles and uses therefor
|
|
WO2010056143A1
(en)
|
2008-11-13 |
2010-05-20 |
Instituto De Medicina Molecular |
The use of adjuvant to facilitate the induction of immune tolerance
|
|
EA201100765A1
(ru)
|
2008-12-15 |
2012-04-30 |
Бинд Биосаиэнсис |
Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
|
|
MX2011007559A
(es)
|
2009-01-20 |
2011-12-06 |
Myelin Repair Foundation Inc |
Composiciones y metodos para induccion de tolerancia antigeno-especifica.
|
|
EP2218784A1
(en)
|
2009-02-04 |
2010-08-18 |
Universität Leipzig |
Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
|
|
SI2393830T1
(sl)
|
2009-02-05 |
2015-04-30 |
Circassia Limited |
Travni peptidi za cepivo
|
|
KR20100099849A
(ko)
|
2009-03-04 |
2010-09-15 |
동국대학교 산학협력단 |
면역억제제와 트랜스글루타미나제 2의 억제제를 함유한 아토피 피부염 치료용 조성물
|
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
AU2010239689A1
(en)
|
2009-04-21 |
2011-11-03 |
Selecta Biosciences, Inc. |
Immunonanotherapeutics providing a Th1-biased response
|
|
WO2010123501A1
(en)
|
2009-04-22 |
2010-10-28 |
Massachusetts Institute Of Technology |
Innate immune suppression enables repeated delivery of long rna molecules
|
|
MX2011011376A
(es)
|
2009-04-27 |
2012-04-20 |
Immuron Ltd |
Preparacion de inmunoglobulina enriquecida con anti-lps, para utilizarse en tratamiento y/o profilaxis de un trastorno patologico.
|
|
WO2010138193A2
(en)
|
2009-05-27 |
2010-12-02 |
Selecta Biosciences, Inc. |
Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
|
|
JP2012531596A
(ja)
|
2009-06-25 |
2012-12-10 |
サヴィエント・ファーマシューティカルズ・インコーポレイテッド |
Ｐｅｇ化ウリカーゼ療法における血清尿酸をモニタリングすることにより注入反応の危険性および抗体媒介性効果消失を予測するための方法およびキット
|
|
CN107617110A
(zh)
|
2009-08-26 |
2018-01-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
|
AR078161A1
(es)
|
2009-09-11 |
2011-10-19 |
Hoffmann La Roche |
Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento.
|
|
EP2305277A1
(en)
|
2009-09-18 |
2011-04-06 |
Forskarpatent I Syd AB |
Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
|
|
CN101703781A
(zh)
*
|
2009-10-28 |
2010-05-12 |
陕西北美基因股份有限公司 |
一种免疫抑制剂的磁性载药方法
|
|
KR101267813B1
(ko)
|
2009-12-30 |
2013-06-04 |
주식회사 삼양바이오팜 |
향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
|
|
WO2011085231A2
(en)
|
2010-01-08 |
2011-07-14 |
Selecta Biosciences, Inc. |
Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines
|
|
US9228171B2
(en)
|
2010-02-05 |
2016-01-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Regulatory B cells (tBREGS) and their use
|
|
WO2011109833A2
(en)
|
2010-03-05 |
2011-09-09 |
President And Fellows Of Harvard College |
Induced dendritic cell compositions and uses thereof
|
|
US20110272836A1
(en)
|
2010-04-12 |
2011-11-10 |
Selecta Biosciences, Inc. |
Eccentric vessels
|
|
US20110262491A1
(en)
|
2010-04-12 |
2011-10-27 |
Selecta Biosciences, Inc. |
Emulsions and methods of making nanocarriers
|
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
|
BR112012028557A2
(pt)
|
2010-05-07 |
2019-09-24 |
Xoma Technology Ltd. |
uso de um anticorpo anti-il-1b ou de fragmentos de ligação do mesmo.
|
|
CN107029223A
(zh)
|
2010-05-26 |
2017-08-11 |
西莱克塔生物科技公司 |
合成纳米载体联合疫苗
|
|
CA2801891C
(en)
|
2010-06-07 |
2020-10-27 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
EP2600878A4
(en)
|
2010-08-04 |
2014-06-11 |
Univ Duke |
REGULATORY B-CELLS AND ITS USES
|
|
AU2011289579B2
(en)
|
2010-08-10 |
2016-11-17 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
|
WO2012024621A2
(en)
|
2010-08-20 |
2012-02-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
|
|
US20120070493A1
(en)
|
2010-08-23 |
2012-03-22 |
Selecta Biosciences, Inc. |
Targeted multi-epitope dosage forms for induction of an immune response to antigens
|
|
CA2810842C
(en)
|
2010-09-09 |
2018-06-26 |
Micell Technologies, Inc. |
Macrolide dosage forms
|
|
EP2630493A4
(en)
|
2010-10-22 |
2014-05-21 |
Univ Florida |
ANTIGEN-SPECIFIC TOLERANCE-INDUCING MICROPARTICLES AND USES THEREOF
|
|
EP2640190A4
(en)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
MODIFIED NICOTINIC COMPOUNDS AND ASSOCIATED METHODS
|
|
US20120171229A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
BR112013020273A2
(pt)
|
2011-02-08 |
2016-10-18 |
Charlotte Mecklenburg Hospital |
oligonucleotídeos antissenso
|
|
ES2685611T3
(es)
|
2011-02-14 |
2018-10-10 |
The Children's Hospital Of Philadelphia |
Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
|
|
US8654487B2
(en)
|
2011-03-11 |
2014-02-18 |
Siemens Industry, Inc. |
Methods, systems, and apparatus and for detecting parallel electrical arc faults
|
|
US20120244222A1
(en)
|
2011-03-25 |
2012-09-27 |
Selecta Biosciences, Inc. |
Osmotic mediated release synthetic nanocarriers
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US20140155469A1
(en)
|
2011-04-19 |
2014-06-05 |
The Research Foundation Of State University Of New York |
Adeno-associated-virus rep sequences, vectors and viruses
|
|
EP3699286A1
(en)
|
2011-04-20 |
2020-08-26 |
The Trustees of the University of Pennsylvania |
Regimens and compositions for aav-mediated passive immunization of airborne pathogens
|
|
CN107320734A
(zh)
|
2011-04-29 |
2017-11-07 |
西莱克塔生物科技公司 |
从合成纳米载体中控制释放免疫抑制剂
|
|
AU2012256281B2
(en)
|
2011-05-16 |
2017-06-15 |
Genzyme Corporation |
Induction of immune tolerance by using methotrexate
|
|
JP2014521687A
(ja)
|
2011-07-29 |
2014-08-28 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
体液性および細胞傷害性ｔリンパ球（ｃｔｌ）免疫応答を生成する合成ナノキャリア
|
|
WO2013036296A1
(en)
|
2011-09-06 |
2013-03-14 |
Selecta Biosciences, Inc. |
Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers
|
|
EP2753362A4
(en)
|
2011-09-08 |
2015-04-15 |
Univ Florida |
MATERIALS AND METHOD FOR MODULATING IMMUNE SYSTEM REACTIONS
|
|
US8865487B2
(en)
|
2011-09-20 |
2014-10-21 |
General Electric Company |
Large area hermetic encapsulation of an optoelectronic device using vacuum lamination
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
WO2013058812A1
(en)
|
2011-10-19 |
2013-04-25 |
President And Fellows Of Harvard College |
Targeted delivery to pancreatic islet endothelial cells
|
|
EP2591801A1
(en)
|
2011-11-14 |
2013-05-15 |
Universitätsklinikum Hamburg-Eppendorf |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
|
|
EP2782596A4
(en)
|
2011-11-22 |
2015-07-29 |
Philadelphia Children Hospital |
VIRUS VECTORS FOR HIGHLY EFFICIENT TRANSGENIC ADMINISTRATION
|
|
BR112014020325A2
(pt)
|
2012-02-17 |
2017-08-08 |
Childrens Hospital Philadelphia |
composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
|
|
JP6342886B2
(ja)
|
2012-04-18 |
2018-06-13 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ |
Ａａｖカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
|
|
CN109876139A
(zh)
|
2012-04-24 |
2019-06-14 |
俄亥俄州国家创新基金会 |
用于治疗和预防猪繁殖与呼吸综合征的组合物和方法
|
|
BR112015005878A2
(pt)
|
2012-09-17 |
2017-07-04 |
Bind Therapeutics Inc |
nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas
|
|
CN102871966B
(zh)
|
2012-10-19 |
2013-11-20 |
东南大学 |
用于改善雷帕霉素生物利用度的纳米载药颗粒及其制备方法
|
|
US9944918B2
(en)
|
2013-03-15 |
2018-04-17 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)
|
|
US20160038575A1
(en)
|
2013-03-15 |
2016-02-11 |
Haplomics, Inc. |
Compositions and methods for immune tolerance induction to factor viii replacement therapies in subjects with hemophilia a
|
|
AU2014251099B2
(en)
|
2013-04-08 |
2019-01-17 |
The University Of Kansas |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
TWI679019B
(zh)
|
2013-04-29 |
2019-12-11 |
法商賽諾菲公司 |
抗ｉｌ－４／抗ｉｌ－１３之雙特異性抗體調配物
|
|
WO2014179771A1
(en)
|
2013-05-03 |
2014-11-06 |
Selecta Biosciences, Inc. |
Dosing combinations for reducing undesired humoral immune responses
|
|
CN105307641A
(zh)
|
2013-05-03 |
2016-02-03 |
西莱克塔生物科技公司 |
用于降低不期望体液免疫应答的给药组合
|
|
ES2834129T3
(es)
|
2013-06-04 |
2021-06-16 |
Selecta Biosciences Inc |
Administración repetida de agentes inmunoterapéuticos específicos de antígeno no inmunosupresores
|
|
CA2926215A1
(en)
|
2013-10-06 |
2015-04-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modified pseudomonas exotoxin a
|
|
US9276815B2
(en)
*
|
2013-12-27 |
2016-03-01 |
Dell Products L.P. |
N-node virtual link trunking (VLT) systems management plane
|
|
EP2916319A1
(en)
|
2014-03-07 |
2015-09-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Concept for encoding of information
|
|
BR112016020688B1
(pt)
|
2014-03-09 |
2024-01-30 |
The Trustees Of The University Of Pennsylvania |
Vetores virais recombinantes, vírus adenoassociado recombinante, composição farmacêutica, bem como uso dos mesmos
|
|
GB201407322D0
(en)
|
2014-04-25 |
2014-06-11 |
Ospedale San Raffaele |
Gene therapy
|
|
US20150358333A1
(en)
*
|
2014-06-04 |
2015-12-10 |
Grandios Technologies, Llc |
Geo-location and biometric presence security
|
|
US20150359865A1
(en)
|
2014-06-17 |
2015-12-17 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease
|
|
US20160220501A1
(en)
|
2015-02-03 |
2016-08-04 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
|
|
EP3160453A1
(en)
|
2014-06-25 |
2017-05-03 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
|
EA201790551A1
(ru)
|
2014-09-07 |
2017-07-31 |
Селекта Байосайенсиз, Инк. |
Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору
|
|
CN107002096A
(zh)
|
2014-10-06 |
2017-08-01 |
阿罗根有限公司 |
基于aav的基因疗法
|
|
AU2015342968B2
(en)
|
2014-11-05 |
2021-05-27 |
Selecta Biosciences, Inc. |
Methods and compositions related to the use of low HLB surfactants in the production of synthetic nanocarriers comprising a rapalog
|
|
TWI726897B
(zh)
|
2015-07-15 |
2021-05-11 |
日商協和麒麟股份有限公司 |
與人類ｃｒｔｈ２特異性結合之抗體
|
|
WO2017139212A1
(en)
|
2016-02-08 |
2017-08-17 |
Cyta Therapeutics, Inc. |
Particle delivery of rapamycin to the liver
|
|
AU2016392719A1
(en)
|
2016-02-10 |
2018-08-02 |
Pfizer Inc. |
Therapeutic nanoparticles having EGFR ligands and methods of making and using same
|
|
RS65941B1
(sr)
|
2016-03-11 |
2024-10-31 |
Cartesian Therapeutics Inc |
Formulacije i doze pegilovane urikaze
|
|
GB201608323D0
(en)
|
2016-05-12 |
2016-06-29 |
Ucb Biopharma Sprl |
Pharmaceutical compositions
|
|
US10545815B2
(en)
|
2016-08-03 |
2020-01-28 |
Futurewei Technologies, Inc. |
System and method for data redistribution in a database
|
|
US20180071394A1
(en)
|
2016-08-25 |
2018-03-15 |
Selecta Biosciences, Inc. |
Polyester polymer matrices for the delivery of allergens
|
|
CN109922819A
(zh)
|
2016-09-27 |
2019-06-21 |
西莱克塔生物科技公司 |
用于治疗癌症的重组免疫毒素
|
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018093868A1
(en)
|
2016-11-16 |
2018-05-24 |
University Of Florida Research Foundation, Inc. |
Immunoglobulin proteases, compositions, and uses thereof
|
|
US11104887B2
(en)
|
2017-01-03 |
2021-08-31 |
Ethris Gmbh |
Ornithine transcarbamylase coding polyribonucleotides and formulations thereof
|
|
JP2020506890A
(ja)
|
2017-01-07 |
2020-03-05 |
セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． |
合成ナノキャリアにカップリングした免疫抑制剤のパターン化された投与
|
|
EP4599848A3
(en)
|
2017-03-11 |
2025-12-03 |
Cartesian Therapeutics, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
|
WO2019075360A1
(en)
|
2017-10-13 |
2019-04-18 |
Selecta Biosciences, Inc. |
METHODS AND COMPOSITIONS FOR MITIGATING ANTI-VECTOR VIRAL TRANSFER IGM RESPONSES
|
|
KR102717886B1
(ko)
|
2018-02-26 |
2024-10-16 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
약물 전달 시스템
|
|
AU2019265632A1
(en)
|
2018-05-09 |
2021-01-07 |
Yale University |
Particles for spatiotemporal release of agents
|
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
|
EP3823676A1
(en)
|
2018-07-16 |
2021-05-26 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
|
CA3138525A1
(en)
|
2019-04-28 |
2020-11-05 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
|
CA3141863A1
(en)
|
2019-05-28 |
2020-12-03 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
|
US12553041B2
(en)
|
2019-06-04 |
2026-02-17 |
Cartesian Therapeutics Inc. |
Formulations and doses of pegylated uricase
|
|
US20210154324A1
(en)
|
2019-10-21 |
2021-05-27 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
|
IL292770A
(en)
|
2019-11-08 |
2022-07-01 |
Selecta Biosciences Inc |
Formulations and dosages of polyethylene glycol-modified oricase
|
|
MX2022010568A
(es)
|
2020-02-26 |
2022-11-30 |
Selecta Biosciences Inc |
Métodos y composiciones que usan nanoportadores sintéticos que comprenden inmunosupresor.
|
|
CA3174988A1
(en)
|
2020-03-11 |
2021-09-16 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
|
CN120078887A
(zh)
|
2020-09-21 |
2025-06-03 |
上海宝济药业股份有限公司 |
一种药物组合及其应用
|
|
MX2023005224A
(es)
|
2020-11-04 |
2023-07-18 |
Selecta Biosciences Inc |
Composiciones para reducir las respuestas inmunes contra inmunoglobulina proteasas.
|
|
AU2022206197A1
(en)
|
2021-01-05 |
2023-07-13 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
KR20230167405A
(ko)
|
2021-04-09 |
2023-12-08 |
셀렉타 바이오사이언시즈, 인크. |
면역 관용을 증진시키기 위해 고친화도 il-2 수용체 효능제와 조합된 면역억제제를 포함하는 합성 나노담체
|
|
EP4079848A1
(en)
|
2021-04-22 |
2022-10-26 |
Genovis Ab |
Immunoglobulin cleaving enzyme
|
|
US20230140196A1
(en)
|
2021-10-12 |
2023-05-04 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
|
JP2025526816A
(ja)
|
2022-08-11 |
2025-08-15 |
カーティザン セラピューティクス，インコーポレーテッド |
免疫グロブリンプロテアーゼおよびその融合体に関する組成物および方法
|